Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2006-05-01 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HUISSEAU-SUR-COSSON (41350), Loir-et-Cher
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU COSSON : revenue, balance sheet and financial ratios
PHARMACIE DU COSSON is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HUISSEAU-SUR-COSSON (41350),
this company of category PME
shows in 2023 a revenue of 1.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU COSSON (SIREN 490158078)
Indicator
2025
2024
2023
2022
2021
2019
2018
2017
Revenue
N/C
N/C
1 137 315 €
N/C
N/C
N/C
N/C
N/C
Net income
12 190 €
26 633 €
-37 551 €
25 798 €
28 087 €
4 120 €
-60 831 €
52 392 €
EBITDA
N/C
N/C
-55 175 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
-3.3%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DU COSSON generates positive net income of 12 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 52 k€ -> 12 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
12 190 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 85%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
4.207%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
84.758%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
2025
Debt ratio
4.21
7.511
6.442
7.882
9.63
6.261
7.996
4.207
Financial autonomy
84.41
81.569
82.52
81.832
82.5
84.193
80.857
84.758
Repayment capacity
None
None
None
None
None
-1.145
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
-4.63%
None%
None%
Sector positioning
Debt ratio
4.212025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excellent
In 2025, the debt ratio of PHARMACIE DU COSSON (4.21) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
84.76%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent+10 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU COSSON (84.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
-1.15 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE DU COSSON (-1.15) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 152.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
152.665
Liquidity indicators evolution PHARMACIE DU COSSON
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2021
2022
2023
2024
2025
Liquidity ratio
91.678
140.938
124.235
177.362
231.469
164.792
166.726
152.665
Interest coverage
None
None
None
None
None
-3.389
None
None
Sector positioning
Liquidity ratio
152.662025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average
In 2025, the liquidity ratio of PHARMACIE DU COSSON (152.66) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
-3.39x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DU COSSON (-3.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU COSSON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
138 582 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
29
0
0
Customer payment term (days)
0
0
0
0
0
8
0
0
Supplier payment term (days)
0
0
0
0
0
34
0
0
Positioning of PHARMACIE DU COSSON in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU COSSON is estimated at
193 639 €
(range 131 404€ - 303 847€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
131k€193k€303k€
193 639 €Range: 131 404€ - 303 847€
NAF 5 année 2025
Valuation method used
Net Income Multiple
12 190 €
×
15.9x
=193 640 €
Range: 131 405€ - 303 847€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU COSSON with other companies in the same sector:
Frequently asked questions about PHARMACIE DU COSSON
What is the revenue of PHARMACIE DU COSSON ?
The revenue of PHARMACIE DU COSSON in 2023 is 1.1 M€.
Is PHARMACIE DU COSSON profitable?
Yes, PHARMACIE DU COSSON generated a net profit of 12 k€ in 2025.
Where is the headquarters of PHARMACIE DU COSSON ?
The headquarters of PHARMACIE DU COSSON is located in HUISSEAU-SUR-COSSON (41350), in the department Loir-et-Cher.
Where to find the tax return of PHARMACIE DU COSSON ?
The tax return of PHARMACIE DU COSSON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU COSSON operate?
PHARMACIE DU COSSON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart